PRKCQ: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 21:49, 17 March 2025
PRKCQ (Protein Kinase C Theta) is a protein that in humans is encoded by the PRKCQ gene. This protein is a member of the Protein Kinase C (PKC) family of serine/threonine protein kinases which can be activated by calcium and the second messenger diacylglycerol.
Function[edit]
PRKCQ protein is involved in diverse cellular signaling pathways including the B-cell receptor (BCR) signalosome, the Fc epsilon RI-mediated mast cell activation, the T cell receptor (TCR) signaling, and the NF-kappaB signaling pathway. The protein is predominantly expressed in hematopoietic cells.
Clinical significance[edit]
Mutations in PRKCQ have been associated with autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis.
Etymology[edit]
The term PRKCQ is an abbreviation for Protein Kinase C Theta. The term 'Protein Kinase' refers to a type of enzyme that modifies other proteins by chemically adding phosphate groups to them (phosphorylation). 'C' refers to the specific subtype of this enzyme family, and 'Theta' is a further classification within this subtype.


